- Home
- UHS vs ASND Comparison
UHS vs ASND Comparison
Compare UHS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHS
- ASND
- Stock Information
- Founded
- UHS 1978
- ASND 2006
- Country
- UHS United States
- ASND Denmark
- Employees
- UHS N/A
- ASND N/A
- Industry
- UHS Hospital/Nursing Management
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- UHS Health Care
- ASND Health Care
- Exchange
- UHS Nasdaq
- ASND Nasdaq
- Market Cap
- UHS 10.9B
- ASND 12.0B
- IPO Year
- UHS N/A
- ASND 2015
- Fundamental
- Price
- UHS $209.08
- ASND $208.89
- Analyst Decision
- UHS Hold
- ASND Strong Buy
- Analyst Count
- UHS 14
- ASND 16
- Target Price
- UHS $216.77
- ASND $240.75
- AVG Volume (30 Days)
- UHS 688.0K
- ASND 406.6K
- Earning Date
- UHS 10-23-2025
- ASND 11-13-2025
- Dividend Yield
- UHS 0.39%
- ASND N/A
- EPS Growth
- UHS 39.27
- ASND N/A
- EPS
- UHS 18.95
- ASND N/A
- Revenue
- UHS $16,460,285,000.00
- ASND $576,332,355.00
- Revenue This Year
- UHS $9.67
- ASND $102.31
- Revenue Next Year
- UHS $4.93
- ASND $76.44
- P/E Ratio
- UHS $10.92
- ASND N/A
- Revenue Growth
- UHS 9.61
- ASND 54.50
- 52 Week Low
- UHS $152.33
- ASND $118.03
- 52 Week High
- UHS $240.26
- ASND $214.71
- Technical
- Relative Strength Index (RSI)
- UHS 76.29
- ASND 63.81
- Support Level
- UHS $200.90
- ASND $187.25
- Resistance Level
- UHS $205.74
- ASND $214.71
- Average True Range (ATR)
- UHS 4.29
- ASND 6.17
- MACD
- UHS 0.85
- ASND 1.25
- Stochastic Oscillator
- UHS 85.43
- ASND 79.50
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.